OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

INSTITUTE OF HEALTH VISITING

TRUSTEES’ REPORT AND ACCOUNTS

FOR THE YEAR ENDING 31[ST] MARCH 2023

Supporting excellence in health visiting practice to give every child the best start in life

Registered Charity No.1149745 Registered Company No. 08234405 (England and Wales)

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Contents

1.
Report from the Chair and Chief Executive .................................................................................................. 4
2. Trustees report ................................................................................................................................................. 5
Our Mission .......................................................................................................................................................... 5
2022-23 Business Plan: Objectives and activities ................................................................................................. 6
I.
Policy: ................................................................................................................................................... 7
II.
Training: ................................................................................................................................................ 8
III.
Projects and evaluations (including Research): ................................................................................ 8
IV.
Education and workforce: ................................................................................................................ 9
V.
Mental Health:...................................................................................................................................... 9
VI.
Corporate team: ............................................................................................................................. 10
Governance, management and trustees ............................................................................................................ 11
Objectives for the year ahead 2023/2024: ........................................................................................................ 15
Financial Review ................................................................................................................................................. 16
Reserves policy and going concern .................................................................................................................... 16
Independent Auditor’s Report …………………………………………………………………………………………………………………….. 18
Statement of financial activities…………………………………………………………………………………………………………………….21
Balance sheet………………………………………………………………………………………………………………………………………………..22
Statement of cash flows………………………………………………………………………………………………………………………………. 23
Notes to the financial statements ………………………………………………………………………………………………………………. 24

2

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Company Information For the year ended 31 March 2023

Reference and Administrative Details of the Charity, its Trustees and Advisers

Company name Institute of Health Visiting
Company number 08234405
Charity number 1149745
Working name iHV
Trustees Pamela Goldberg*, OBE, FRSA, Chair (from 28 July 2016)
Prof Dame Sarah Cowley DBE, BA, PhD, PGDE, RN, RHV, HVT (from 12
October 2022)
CEO
Principal address
Auditor		 Dave Roberts (from 28 October 2019)
Sam Carlisle (from 5 May 2020)
Dr Karen Whittaker BN, MSc, PGCE, PhD, FiHV (until 14 June 2022)
Dr. Qingzhi Fan PhD (until 20 April 2022)
Prof Helen Bedford PhD, MSc. RGN, RHV, FFPH, FRCPCH, FiHV (from 26
January 2021)
Dr Sharin Baldwin PhD, MSc, PG Dip, BSc (Hons), HV, RM, RN, QN, FiHV (from
13 October 2021 to 19 April 2023)
Alis Rasul (from 13 October 2021)
Theresa Bishop (from 13 October 2021)
Christina Liu (Treasurer – from 20 April 2022)
Alison Morton, MRes, BSc (Hons) RGN, RHV, DN cert. FiHV (from 26 April
2021; previously Acting Executive Director from 1 January 2021)
* Members of the Finance & General Purposes Committee
John Snow House
59 Mansell Street
London E1 8AN
Chiene + Tait LLP (Trading as CT)
61 Dublin Street
Edinburgh
EH3 6NL
Bankers The Co-operative Bank plc
City Office
80 Cornhill
London
EC3V 3NJ
Lloyds Bank plc
PO Box 1000
BX1 1LT
Legal Advisors Bates, Wells and Braithwaite
2 - 6 Cannon Street
London
EC4M 6YH

3

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

1. Report from the Chair and Chief Executive

The Board presents its annual report together with the accounts of the Institute of Health Visiting (iHV) for the year ended 31 March 2023. The last year has been a historical milestone for the Institute as we celebrated our 10[th] anniversary as an organisation.

Since our launch as a centre of excellence for health visiting on 28 November 2012, there is so much to celebrate at this important time in our organisation’s growth. Every week, thousands and thousands of families are supported by health visitors across the UK. The profession has a history that spans more than 150 years. During this time, health visitors have adapted their work to address the most pressing public health challenges of the day and the needs of the communities they serve. In many ways, the current landscape of change is no different - adapting to change is in our profession’s DNA. As we look back over the last ten years, the commitment and innovation that health visitors have shown has been awe-inspiring during some of the most challenging times. Now, as we navigate the wake of the pandemic and a cost-of-living crisis, it is clear that health visitors are needed more than ever, in a world where inequalities are widening, and public health challenges pose the biggest threats to the nation’s health.

In addition to this report, the iHV published its public-facing Annual Report in December 2022 which provides an overview of our work that has been delivered by the iHV team and in collaboration with so many partner organisations, practitioners and parents. The achievements are testament to the hard work, clear vision and dedication of so many who have played their part in building the Institute into the successful organisation that it is today.

The golden thread that unites us is our shared belief that health visitors really do make a difference alongside a dogged determination to improve the health of babies, children, families and communities; this is woven through each year of our organisation’s history and will continue to guide us into the future. The Institute remains in a strong position, we have a seat at the table in multiple national stakeholder forums, and we have grown our partnerships this year, with numerous high-profile reports and endorsements for the profession.

Our work remains focused on supporting our growing membership through resources, events and training. We also lead a range of projects, and partner in research focused on key public health priorities. We continue to engage with our members and other stakeholders throughout the year to identify the current opportunities and challenges facing the profession. This frontline practitioner intelligence has provided valuable data on the state of child health and the health visiting profession across the UK that we have shared with policymakers in numerous national forums.

Whilst the profession faces significant challenges, particularly in England where there are now 40% fewer health visitors compared to 2015, practitioners have risen to the challenges to support as many families as possible. This year, Unicef UK recognised the vital work of health visitors in their “Early Moments Matter” campaign, describing the profession as “The backbone of the early years… a safety-net around all families”.

Influencing policies affecting health lies at the heart of health visiting and our work at the iHV. We know that we cannot do this alone. Throughout the year we have actively sought to build new alliances and strengthen well established ones. We are indebted to so many partner organisations, parents and practitioners who have supported our work to demonstrate the value of an effective health visiting service, with benefits accruing to the NHS, primary care, education and social care.

This annual report looks back at our performance and the progress that we have made in the last year. We are proud of the Institute and how the team has innovated and led on health visiting policy and practice, drawing on the best evidence to develop new and improved ways to support health visitors, promote inclusion and reduce health inequalities for babies, children and families.

Our organisation remains in a strong position to address the challenges we now face as we look to ensure that every child has the ‘best life from the start’, regardless of where they live, and to rebuild a health visiting service fit for the future. We are extremely grateful to our supporters, members, funders and friends. This coupled with the energy and expertise of our staff, expert advisers, consultants and trustees makes the iHV the effective organisation that it is. We thank them for their ongoing support.

4

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

2. Trustees report

Our Mission

The Institute of Health Visiting* was founded in 2012 as a registered charity under the Charities Act. It is also registered as a company limited by guarantee under the Companies Act 2011.

[*Working titles for the Institute of Health Visiting are ‘The Institute’ and ‘iHV’].

The Institute is registered as a charity in England and Wales and operates throughout the United Kingdom as an independent charity, professional body and Centre of Excellence for health visiting – established to strengthen the quality and consistency of health visiting practice, so that health visitors can effectively respond to the health needs of all babies, children, families and communities enabling them to achieve their optimum level of health, thereby reducing health inequalities.

Our Values

We believe that:

We are fully committed to the active promotion of equality, diversity and inclusion in everything that we do. We want to enable an organisational culture that values diversity and we are committed to eliminating unlawful discrimination.

Our Vision and Objectives

Our Vision requires health visitors to play their fullest part within an integrated system to reduce health inequalities that arise in childhood and for the UK to achieve health outcomes on a par with the best in the world.

The iHV was established to:

5

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

2022-23 Business Plan: Objectives and activities

The key objectives of the iHV Business Plan for 2022/23 were developed by the Senior Management Team, in partnership with the Board, to support the iHV’s Core Mission. These focus on 8 key objectives:

1.

Policy Influence:

2. Provide targeted professional and leadership development to enhance capability:

3. Membership:

4. Quality and delivery:

5. People development/ infrastructure and helping you to do your job:

6. Equality of Opportunity:

7. Money:

8. Environmental and sustainability:

Institute’s activities against planned objectives in 2022/23

The Institute has built on its success as the most rapidly growing professional body and voice for health visiting in the UK. Our day-to-day activity is organised under six work programmes aligned to the six teams within the organisation, with 28 members of staff.

6

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

I. Policy:

This year, we have continued with our objective to raise the profile of health visiting and make the case for a high-quality health visiting service for all families, regardless of where they live in the UK. We have also focused on influencing local policies and supporting quality improvement by working more closely with local government and health visiting providers, as well as across all UK nations.

The Institute remains in a strong position, we have a seat at the table in multiple national forums and respond to numerous requests for written and oral evidence for national policy roundtables, inquiries and All-Party Parliamentary Groups. We have also proactively worked with others to raise the parliamentary profile of babies, young children and families. Our publications are often cited by policy makers and prestigious thinktanks who continue to approach us for evidence and opportunities for partnership working.

Over the last year, our policy work has included:

7

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

Evidence submissions/ briefings/ letters:

This year, we submitted responses to numerous calls for evidence, including:

II. Training:

2022/23 has been a successful year for our training team. Training team highlights include:

III. Projects and evaluations (including Research):

We receive regular requests from organisations who are keen to partner with us and are increasingly seen as the ‘go to’ partner for projects and research related to health visiting and public health for babies, young children and families. Our proven track record of delivering high quality products within timescale and budget are key elements of our success, alongside our ability to work flexibly and with others.

This year, we have delivered a number of successful projects and grant-funded work in partnership with academic, professional and third sector organisations. In recognition of her nursing leadership of the iHV’s ‘Changing conversations around autism programme’, we were delighted to hear that Vicky Gilroy, our Head of Projects and Evaluations was recognised as one of the Burdett Trust for Nursing’s ‘Heroes’ at their 10th Anniversary awards at the end of June 2022.

The following summary provides examples of our projects and partners during 2022/2023:

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

IV. Education and workforce:

Our work to support health visitor education and career progression focused on the following areas:

V. Mental Health:

The last year has provided many opportunities for us to raise the importance of family mental health and wellbeing and the role of the health visitor as an essential part of an effective, integrated perinatal and infant mental health (PIMH) system.

9

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

VI. Corporate team:

Membership: The iHV relies on its unrestricted income from member donations to support the delivery of its charitable objectives - collectively, this accounts for around 25% of our annual income. Despite the enormous challenges facing the health visiting profession, our membership has increased by 32% since March 2022. We have enjoyed a significant growth in our corporate membership – with a smaller but still significant growth in individual memberships.

Meeting the needs of our members remains a priority. We engage regularly with our members through iHV Networking events, iHV Insights events, monthly iHV Times newsletter, our Health Visitor Advisory Forum and annual survey. In December 2022, we launched our iHV Podcasts to provoke discussion on key topics. Our growing suite of resources for members, including our Good Practice Points, Parent Tips, web-based resources and publications, remain popular. We also regularly promote the work of our members through Voices blogs and news stories.

We charge a modest fee for iHV membership to support our ambition that all health visitors will become members. We have not increased our individual membership fees for many years and we deferred an increase last year due to the rising cost of living, inflationary pressures and significant workforce challenges.

Conferences:

Our conferences attract growing numbers of delegates and we have delivered three successful conferences as well as our celebratory 10[th] Anniversary Event this year. We were delighted to be able to move some of these events back to ‘in-person’ or hybrid events, following COVID restrictions since 2020:

10

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

Sector-led Improvement work:

This year we have worked with a number of local authorities to support their work to drive improvements in health visiting practice. Our Sector-Led Improvement work predominantly comprises of short, time-limited projects that support quality assurance and quality improvement in practice, as well as bespoke work on specific issues including workforce.

International

PATH: This 4-year European Interreg 2 Seas PATH project facilitates cross-border collabora�on between England, France, the Netherlands and Belgium and we are proud to have worked alongside our partners since 2019 to successfully deliver a suite of outputs to promote posi�ve family perinatal mental health. Our final year ac�vi�es that included:

Communications and media: Our communications and design team are central to the success of the iHV, managing our external communications and providing bespoke imagery, quality assurance and proof reading of all our publications and communications. Our work continues to attract good media interest including: ITV News, Channel 5 News, BBC Radio, Radio Islam, New York Times, Daily Telegraph, Evening Standard, Daily Mail, Sunday Mirror, the Independent, MSN, Yahoo news, Scottish Sun, Nursing in Practice, Nursery World, News Medical Life Sciences, CYP Now, HSJ, BMJ, the Mirror, Nursing Times and Dame Andrea Leadsom 1001 Critical Days podcast.

Governance, management and trustees

Governing Document: The Institute of Health Visiting is governed by its Articles of Association and the Board has ultimate authority and responsibility for directing and governing the charity. The Board is comprised of Trustees selected from a range of backgrounds to support the organisation’s objectives. The constitution of the Board is reviewed annually, and the Trustees hold an annual away day for organisational and strategic planning in October each year.

The Trustees meet formally as a Board on a quarterly basis. In between Board meetings, some Trustees are actively engaged with the larger funded projects, providing governance oversight and expert advice in their

11

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

role as the Chair of Project Steering Groups, and/ or membership of ‘Task and Finish’ groups focused on specific iHV workstreams. The Chair, CEO, Honorary Treasurer and independent accountants meet outside the Board meetings, as a Finance and General Purposes committee focused on the organisation’s finance and business planning. The input of the Trustees supplements the direct management role of the CEO.

Change to Trustees: Trustees can serve up to two terms, each of three years, in office before being required to step down. In December 2022, the charity announced that Pamela Goldberg, our current Chair, would step down in July 2023 when her second term expires. Following an external recruitment and interview process, we are delighted to have appointed Sue Tokley as the new iHV Chair. Sue brings a wealth of experience and skills from her background as a Chief Nurse and in charity work. Sue’s appointment was unanimously approved by the Board in April 2023.

In January 2022, our Treasurer Sue Gallone stepped down at short notice due to a change in her personal circumstances; following an open recruitment process Christina Lui was welcomed as our new Honorary Treasurer following the Board’s approval on 20 April 2022. We also welcomed the return of Prof Dame Sarah Cowley as a Trustee in October 2022 following a break of one year after she reached the maximum term in her role as one of the iHV’s first trustees.

Following her appointment on the iHV staff team, Sharin Baldwin stepped down from her position as Trustee at the April Board meeting prior to taking up her post as Senior Research Fellow at the iHV in July.

Governance: The CEO is supported by the Senior Management Team (SMT) who generally meet monthly to review organisational performance, governance and risks in the Governance meeting, with escalation of urgent matters to the Trustees between Board meetings. In March, the SMT consolidated their February and March meetings into an ‘awayday’ to support business planning which is built on the key priorities identified by the Board of Trustees at their awayday in October. The Business Plan is presented to the Board in April for final approval, alongside the updated risk log and mitigations.

Policies and procedures: To support governance, the iHV has a range of policies that are reviewed on a regular basis, and/ or updated in response to changes to national policy. This year we have reviewed and updated the following policies and alerted staff to the changes:

Financial systems and IT upgrade: During August our Corporate administrative team reviewed and cleansed our entire salesforce database to ensure that we remain compliant with GDPR. This is scheduled annually with smaller 3 monthly reviews during the year. We have continued with our programme to rationalise our IT systems and software packages to reduce duplication and improve interoperability, including the effective synchronisation between Salesforce, Wordpress and Moodle for iHV Learn. Our use of Xero online accounting software, introduced last year, has brought numerous benefits, improving governance and supporting better invoicing and debt management. Our accountancy support is provided by the independent accountants, JS2.

Sustainability: We are committed to play our part in improving environmental sustainability. This year, we reviewed and updated our Sustainability Policy and set out four key business objectives that are included in our Business Plan for 2023/24.

Partnerships: The Institute is independent of, but has benefited from, close working relations with the Royal Society for Public Health (RSPH) which continues to provide the Institute with back-office support. The Institute pays the RSPH a small honorarium for this support and use of their London meeting rooms when

12

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

needed. Alongside its income from membership fees, the Institute receives income through grants and consultancy work with the following organisations:

Secondments:

Grant/ project funders:

Staffing of the Institute

Our staff play a crucial part in delivering the iHV Mission. The Institute is a growing organisation with 28 members of staff employed on a range of permanent and temporary contracts to meet our core business, training and project work. This year we have seen some staff changes as two long-standing members of the team retired, one went on maternity leave and two members of our corporate team left the organisation. We have welcomed five new members of staff to our team and have been pleased by the calibre of applicants.

All staff have personal objectives aligned to the iHV annual Business Plan and these are reviewed regularly through an ongoing Personal Development Review process. In addition, the iHV employs individuals as independent consultants and trainers, as needed, to support programmes of work.

Supporting staff wellbeing remains a priority. Our senior management team is working well - the ‘Head of’ departments are actively involved in financial and workforce forecasting and planning for their teams, to provide better oversight and management of workflow, workload and risks. Staff are also supported through regular 1:1s, monthly team meetings, smaller team meetings and our annual team awayday in the summer. This year, we reviewed our employee benefits and non-pay rewards, and the Board has increased the annual leave entitlement for staff who have worked for the iHV for more than two years (5 days pro rata).

13

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

Quality assurance: Quality underpins all that the iHV does. All projects have a project governance group chaired by either the CEO or a Trustee. This year we have further developed our Quality Assurance processes, Quality Assurance toolkit and Ethical Collaborations Policy to guide our work.

Risks: We have clear processes in place for risk management to ensure that risks are identified, managed and escalated to the iHV Board in a timely way to support business continuity and quality control. Each department undertakes ongoing risk assessments to identify and mitigate risks, escalating these through the iHV Governance group (the Heads of Department are responsible for managing their department risks and these are graded and recorded on their monthly departmental score cards). Risks are also recorded on the organisation’s risk register. Risks are formally reviewed by the Senior Management Team in the monthly iHV Governance Group and quarterly by the Board (or more frequently by exception) to support organisational decision making and risk mitigation.

The three main areas of risk are:

Financial risks – there is an on-going risk that the iHV could fail to attract sufficient income to maintain its core functions and staff costs, especially with a recent expansion to the staff numbers. In addition, due to uncertainties around inflation, there is a risk that workstream/ programme requirements may extend beyond the costed deliverables, leading to rising costs in excess of the indicative budget.

Mitigation: The Chair and Treasurer meet regularly with the CEO, who has the responsibility to generate income and ensure sustainable funding. Our income streams are as diversified as possible to spread the risk and the iHV has healthy reserves. Accounts are monitored closely through monthly management accounts. All Heads of Department have sight of budgets. All teams use project management skills to manage costs, time and quality, with MoSCoW prioritisation. Business planning is managed through our bi-monthly Business Development Group, and we have an internal bid writing team to maximise success. Inflation poses an ongoing threat for pay and non-pay costs. Our inflationary pay award is based on affordability and is mapped against similar charities/ CPI figure and projected inflation. We use fixed term contracts for any additional staffing for specific projects, using consultancy by exception due to inflated costs. Our fees are reviewed regularly to ensure they cover our costs. We have clear processes in place for financial governance/ sign off – and use Xero finance management system to track invoices, income and expenditure.

Quality/ Reputational risks – there is the risk that staff, or those representing the iHV, inadvertently misrepresent the charity which could damage the reputation of the organisation. There is also a risk that iHV products/ website are not of the desired quality or contain out of date/ inaccurate information.

Mitigations: Careful staff recruitment, PDR, training and performance management processes are in place to ensure that all iHV staff have the necessary skills and capabilities to represent the organisations and ensure iHV outputs comply with our Quality Assurance processes, including agreed levels of senior management ‘sign-off’. Any incidents are recorded, and an action plan developed, including sharing the learning with the wider team through the Governance and Professional meetings (fortunately, these are very rare).

Staff wellbeing: There is a risk that iHV workload may exceed staffing capacity, and staff wellbeing may be impacted by the wider impacts of the cost-of-living crisis – as a result, there is a risk that staff wellbeing will be affected which will impact on staff sickness, iHV delivery with reputational and financial risks.

Mitigations: Continuous workflow mapping and planning is undertaken by the Heads of Departments in all teams, with proactive recruitment to cover work and avoid excessive workloads, particularly when new contracts are achieved. Business continuity planning is in place and staff are trained to ensure that there is adequate cover for all roles to cover unexpected staff losses. We also use a pool of zero-hour contract staff for cover as required and utilise staff from other departments to fill temporary gaps. Staff wellbeing is reviewed at individual 1:1s with line managers and we support team wellbeing through our annual 2-day ‘Awaydays’, flexible working policy and signposting to additional support where needed.

14

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

Objectives for the year ahead 2023/2024:

The iHV Business Plan and objectives are developed collaboratively by the Board, Senior Management Team and staff to support our organisation’s mission and charitable objectives. Our key objectives for 2023/24 are:

1) Influence policy to improve health, reduce inequalities and strengthen health visiting:

2) Support quality improvement in health visiting:

3) Build professional skills and knowledge to enhance health visiting workforce capability and leadership development

4) Support our members and meet their needs

How we work in a changing world:

5) Make the iHV a great place to work and develop

15

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

6) Good governance, infrastructure, financial and quality management:

7) Equity, diversity and inclusion

8) Environmental and sustainability

Financial Review

The Institute has finished the year in a better position than expected with a surplus of £164,195 (2022: £186,009). Our total income has decreased from £1,575,756 in 2021/22 to £1,563,939 in 2022/23. This increase on prior year is due to an increased uptake in corporate memberships and larger number of training sessions/increased interest in online training sessions.

Expenditure in the year also increased to £1,399,744 (2022: £1,389,747) due to increased consultancy spend on restricted projects along with increased staffing costs.

Reserves policy and going concern

In assessing the overall level of reserves, the Board aims at all times to maintain sufficient unrestricted funds to ensure it remains solvent going forward, this includes at least 6-month’s running costs.

The Institute currently holds total reserves of £1,146,697 (2022: £982,472) of which £971,476 (2022: £760,674) are free reserves (unrestricted funds). This equates to approximately 7 months standard running costs. The Institute has designated £150,000 to use to replace its website and improve interoperability between its numerous IT systems commencing in 2023/24. This will support us to achieve sustainability for future years.

16

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Trustee’s Report For the year ended 31 March 2023

The Trustees have reviewed the charity’s financial position, taking into account current performance, the ongoing economic challenges, the satisfactory levels of reserves and cash at year end and projections. They have considered future plans, along with internal processes and systems for managing financial and operational risks. As a result, the Trustees have a reasonable expectation that the charity has adequate resources and infrastructure to continue operating for the foreseeable future.

Statement of Trustees’ Responsibilities

The Trustees (who are also directors for the purposes of company law) are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the Trustees are aware:

Public Benefit

The Trustees have referred to the guidance contained in the Charity Commission’s general guidance on public benefit when reviewing the aims and objectives and in planning the future activities. In particular, the Trustees consider how planned activities and grant making will contribute to the aims and objectives they have set. The Trustees consider the current policy for grant making and the current activities deliver public benefit. Details of the objects which form the basis of this are given in this report.

Auditors

Our auditors CT have now completed their third audit on behalf of the charity.

This report of the Board of Trustees has been prepared taking advantage of the small companies exemption of section 415A of the Companies Act 2006.

Pamela Goldberg Chair DATE 02 August 2023

17

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Independent Auditor’s Report For the year ended 31 March 2023

Independent auditor’s report to the members of Institute of Health Visiting

Opinion

We have audited the financial statements of Institute of Health Visiting for the year ended 31 March 2023 which comprise the Statement of Financial Activities, the Balance Sheet, the Statement of Cash Flows and the notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the trustees’ annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

18

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Independent Auditor’s Report For the year ended 31 March 2023

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees’ Annual Report (which incorporates the directors' report).

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement set out on page 17, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of financial statements which give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We gained an understanding of the legal and regulatory framework applicable to the charitable company and the sector in which it operates and considered the risk of acts by the charitable company which were contrary to applicable laws and regulations, including fraud. This included but was not limited to the Companies Act 2006 and the Charities Act 2011.

19

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Independent Auditor’s Report For the year ended 31 March 2023

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion.

We focused on laws and regulations that could give rise to a material misstatement in the charitable company's financial statements. Our tests included, but were not limited to:

There are inherent limitations in an audit of financial statements and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. We also addressed the risk of management override of internal controls, including testing journals and evaluating whether there was evidence of bias by the trustees that represented a risk of material misstatement due to fraud.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Jeremy Chittleburgh CA (Senior Statutory Auditor)

For and on behalf of CT Chartered Accountants and Statutory Auditor 61 Dublin Street Edinburgh EH3 6NL

09 August 2023 Date:…………………….

20

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Statement of financial activities (incorporating an income and expenditure account)

For the year ended 31 March 2023

2023 2022
Unrestricted Restricted Total Unrestricted Restricted Total
Note £ £ £ £ £ £
Income from:
Donations 2 34,883 - 34,883 34,111 - 34,111
Charitable activities: 3
Grant 125,170 325,967 451,137 139,136 490,532 629,668
Education & Training 688,792 - 688,792 556,017 50,000 606,017
Membership 383,639 - 383,639 303,956 - 303,956
Other 2,750 - 2,750 1,871 - 1,871
Interest 2,738 - 2,738 133 - 133
Total income 1,237,972 325,967 1,563,939 1,035,224 540,532 1,575,756
Expenditure on:
Charitable activities 4 1,024,820 374,925 1,399,744 863,494 526,253 1,389,747
Total expenditure 1,024,820 374,925 1,399,744 863,494 526,253 1,389,747
Transfer between funds (2,351) 2,351 - 59,640 (59,640) -
Net movement in funds 210,802 (46,607) 164,195 231,370 (45,361) 186,009
Reconciliation of funds:
Total funds brought forward 760,674 221,798 982,472 529,304 267,159 796,463
Total funds carried forward 971,476 175,191 1,146,667 760,674 221,798 982,472

All of the above results are derived from continuing activities. There were no other recognised gains or losses other than those stated above. Movements in funds are disclosed in Note 15 to the financial statements.

21

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Balance sheet

Balance sheet
As at 31 March 2023 Company no. 08234405
Note
Fixed assets:
10
Current assets:
11
Liabilities:
12
15
Cash at bank and in hand
Tangible assets
Debtors
The funds of the charity:
Creditors: amounts falling due within one year
Net current assets
Total net assets
Restricted income funds
Unrestricted income funds:
General funds
Total charity funds
Designated funds		 £
336,060
1,315,222		 2023
£
10,409
10,409
1,136,258
1,146,667
175,191
150,000
821,476
1,146,667		 2022
£
13,647
13,647
390,339
1,032,009
1,651,282
(515,024)		 1,422,348
(453,523)
968,825
982,472
221,798
-
760,674
982,472

02 August 2023

Approved by the trustees on ……………………………….and signed on their behalf by:

……………………………………………………… ………………………………………………………… Pamela Goldberg Christina Liu Chair Treasurer

22

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Statement of cash flows

For the year ended 31 March 2023
Note
a
b
a)
Depreciation charges
Dividends, interest and rent from investments
(Increase) in debtors
Increase/(decrease) in creditors
Net cash provided by / (used in) operating activities
b) Analysis of changes in net debt
Cash in hand and at bank
Total cash and cash equivalents
Reconciliation of net income / (expenditure) to net cash
flow from operating activities
Net income / (expenditure) for the reporting period (as per
the statement of financial activities)
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Cash flows from operating activities
Change in cash and cash equivalents in the year
Net cash provided by / (used in) operating activities
Cash flows from investing activities:
Interest from investments
Purchase of fixed assets		 At 1 April
2022
£
1,032,009		 2023
£
285,575
2,738
(5,100)
283,213
1,032,009
1,315,222
2023
£
164,195
8,338
(2,738)
54,279
61,501
285,575
Cash flows
£
283,213
283,213		 2022
£
51,545
133
(12,218)
39,460
992,549
1,032,009
2022
£
186,009
8,343
(133)
(221,402)
78,728
51,545
At 31 March
2023
£
1,315,222
1,315,222
1,032,009

23

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Notes to the financial statements

For the year ended 31 March 2023

1 Accounting policies

a) Basis of preparation

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP FRS 102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy or note.

The trustees consider that there are no significant areas of estimation or judgement.

b) Public benefit entity

The charitable company meets the definition of a public benefit entity under FRS 102.

c) Going concern

The trustees consider that there are no material uncertainties about the charitable company's ability to continue as a going concern.

The trustees do not consider that there are any sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next reporting period.

The Trustees have reviewed the charity’s financial position, taking into account current performance, the satisfactory levels of reserves and cash at year end and projections. They have considered future plans, along with internal processes and systems for managing financial and operational risks. As a result, the Trustees have a reasonable expectation that the charity has adequate resources and infrastructure to continue operating for the foreseeable future.

d) Income

Income is recognised when the charity has entitlement to the funds, any performance conditions attached to the income have been met, it is probable that the income will be received and that the amount can be measured reliably.

Income from government and other grants, whether ‘capital’ grants or ‘revenue’ grants, is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred.

Income received in advance of the provision of a specified service is deferred until the criteria for income recognition are met.

e) Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the bank.

f) Fund accounting

Restricted funds are to be used for specific purposes as laid down by the donor. Expenditure which meets these criteria is charged to the fund.

Unrestricted funds are donations and other income received or generated for the charitable purposes.

g) Expenditure and irrecoverable VAT

Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably. Expenditure on charitable activities includes the costs of undertaken to further the purposes of the charity and their associated support costs.

Irrecoverable VAT is charged as a cost against the activity for which the expenditure was incurred.

24

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Notes to the financial statements

For the year ended 31 March 2023

h) Allocation of support costs

Expenditure is allocated to the particular activity where the cost relates directly to that activity. However, the cost of overall direction and administration of each activity, comprising the salary and overhead costs of the central function, is apportioned on the following basis which are an estimate, based on staff time, of the amount attributable to each activity.

i) Tangible fixed assets

Fixed assets are stated at original historical cost less aggregate depreciation and are only capitalised at a threshold exceeding £1,000. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset on a reducing balance basis over its estimated useful life as follows.

Computer equipment 3 years straight line

j) Debtors

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

k) Cash at bank and in hand

Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account. Cash balances exclude any funds held on behalf of service users.

l) Creditors and provisions

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

2 Income from donations and legacies

Donations
Gift Aid		 2023
Total
£
4,977
29,906		 2022
Total
£
2,654
31,457
34,883 34,111

All donations and gift aid are unrestricted in both the current and prior year.

25

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Notes to the financial statements

For the year ended 31 March 2023

Income from charitable activities
Current year
Core
Mental Health Team
Consultancy, Innovation & Enterprise
AIM Foundation ®
AIM Healthy Weight Healthy Nutrition
PATH
Baby Breathe
NSPCC LSSP
Genomics
Family Action Stockton PSS
Demontfort University
0-19 Research Network
Burdett CVD Project
Strep A
Prior year
Core
AIM Foundation ®
AIM Healthy Weight Healthy Nutrition
UK Active This Mum Can
PATH
Delivery Of Different News 2
Baby Breathe
AIMS Southern Health NHS Foundation Trust (SHFT)
NSPCC LSSP
Genomics
NHS VCSE
Family Action Stockton PSS
Public Health England Sexual Reproductive Health
Demontfort University
Total income from charitable activities 2023
Education & Training
Membership
Total income from charitable activities 2023
Education & Training
Membership
Other
Other
Grants:
Grants:		 Unrestricted
£
77,882
406
5,768
-
-
-
-
-
4,151
12,461
-
24,502
-
-		 £
-
-
-
45,000
34,660
61,130
40,128
22,378
-
-
8,500
-
68,146
46,025
Restricted		 2023
Total
£
77,882
406
5,768
45,000
34,660
61,130
40,128
22,378
4,151
12,461
8,500
24,502
68,146
46,025
125,170
688,792
383,639
2,750		 325,967
-
-
-		 451,137
688,792
383,639
2,750
1,075,181 - 1,075,181
1,200,351 325,967 1,526,318
Unrestricted
£
8,143
-
-
26,388
-
58,651
-
18,067
-
15,387
-
12,500
-
-		 £
94,108
40,000
34,917
-
95,596
-
39,232
-
60,963
-
77,066
-
45,250
3,400
Restricted		 2022
Total
£
102,251
40,000
34,917
26,388
95,596
58,651
39,232
18,067
60,963
15,387
77,066
12,500
45,250
3,400
139,136
556,017
303,956
1,871		 490,532
50,000
-
-		 629,668
606,017
303,956
1,871
861,844 50,000 911,844
1,000,980 540,532 1,541,512

26

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Notes to the financial statements

For the year ended 31 March 2023

4 Analysis of expenditure

Current year
Staff costs (Note 6)
Direct Costs
Publicity
Travel & Subsistence
Premises costs
Office costs
Legal & Consultancy
Accountancy & Bookkeeping Fees
Audit fees
Sundry Expenses
Depreciation
Irrecoverable VAT
Support costs
Governance costs
Total expenditure 2023
Prior year
Staff costs (Note 6)
Direct Costs
Travel & Subsistence
Premises costs
Office costs
Legal & Consultancy
Accountancy & Bookkeeping Fees
Audit fees
Sundry Expenses
Depreciation
Irrecoverable VAT
Support costs
Governance costs
Total expenditure 2022		 Charitable
activities
£
989,817
113,398
-
-
-
-
-
-
-
-
-
-
1,103,215
281,272
15,257
1,399,744
Charitable
activities
£
993,026
205,536
-
-
-
-
-
-
-
-
-
1,198,562
177,582
13,603
1,389,747		 Governance
costs
£
8,928
-
-
-
-
-
-
-
6,329
-
-
-
15,257
-
(15,257)
-
Governance
costs
£
8,553
-
-
-
-
-
-
5,050
-
-
-
13,603
-
(13,603)
-		 Support costs
£
56,953
-
86
19,870
16,030
114,790
1,057
26,550
2,160
22,223
8,338
13,215
281,272
(281,272)
-
-
Support costs
£
39,053
-
3,903
14,521
72,882
960
21,260
-
4,161
8,343
12,499
177,582
(177,582)
-
-		 2023 Total
£
1,055,698
113,398
86
19,870
16,030
114,790
1,057
26,550
8,489
22,223
8,338
13,215
1,399,744
-
-
1,399,744
2022 Total
£
1,040,632
205,536
3,903
14,521
72,882
960
21,260
5,050
4,161
8,343
12,499
1,389,747
-
-
1,389,747

27

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Notes to the financial statements

For the year ended 31 March 2023

5 Net income for the year

This is stated after charging / crediting:

2023 2022
£ £
Depreciation 8,338 8,343
Audit fee 6,350 5,050

6 Analysis of staff costs, trustee remuneration and expenses, and the cost of key management personnel

Staff costs were as follows:

S
S
Seconded staff
Salaries and wages
Social security costs
Employer’s contribution to defined contribution pension schemes		 2023
£
715,521
66,530
146,216
127,431		 2022
£
704,036
77,293
137,544
121,759
1,055,698 1,040,632

No employees earned (excluding employer pension) between £60,000 and £70,000 during the year (2022: 0).

Two employees earned (excluding employer pension) between £70,000 and £80,000 during the year (2022: 2).

The total employee benefits including employers pension contributions of the key management personnel was £94,997 (2022: £91,230). The key management personnel were made up of the Executive Director and Head of Operations.

The charity trustees were not paid or received any other benefits from employment with the charity in the year (2022: £nil).

During the year, no trustee was reimbursed for travel and subsistence costs (2021: 0 trustees £Nil) relating to attendance at meetings of the trustees.

7 Staff numbers

The average number of employees (head count based on number of staff employed) during the year was as follows:

Support
Charitable activity		 2023
No.
26.0
3.0		 2022
No.
27.0
2.0
29.0 29.0

28

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Notes to the financial statements

For the year ended 31 March 2023

There were no related party transactions including donations from related parties which are outside the normal course of business in the current or preceding year.

9 Taxation

The charitable company is exempt from corporation tax as all its income is charitable and is applied for charitable purposes.

10 Tangible fixed assets

At the end of the year
At the end of the year
At the start of the year
Charge for the year
At the start of the year
Additions in year
At the end of the year
Cost
Depreciation
Net book value
At the start of the year		 Computer
equipment
£
34,644
5,100
39,744
20,997
8,338
29,335
10,409
13,647

All of the above assets are used for charitable purposes.

11 Debtors

2023
£
T
224,180
O
111,880
336,060
2023
£
T
21,987
T
83,545
Other creditors
20,271
389,221
515,024
Other debtors
Creditors: amounts falling due within one year
Deferred income
Trade debtors
Trade creditors
Taxation and social security
Other creditors and accruals		 2023
£
224,180
111,880		 2022
£
217,506
172,833
336,060 390,339
2022
£
28,854
47,598
80,448
296,623
515,024 453,523

12 Creditors: amounts falling due within one year

29

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Notes to the financial statements

For the year ended 31 March 2023

13 Deferred income

Deferred income comprises membership fees paid in advance.

Balance at the beginning of the year
Amount released to income in the year
Amount deferred in the year
Balance at the end of the year
As at 31 March 2023
Tangible fixed assets
Net current assets
Net assets at the end of the year
As at 31 March 2022
Tangible fixed assets
Net current assets
Net assets at the end of the year
Analysis of net assets between funds		 £
10,409
961,068
General
unrestricted		 2023
£
296,623
(296,623)
389,221		 2022
£
256,561
(256,561)
296,623
389,221 296,623
Restricted
£
-
175,191
 Total funds
£
10,409
1,136,258
971,477 175,191 1,146,667
£
13,647
747,027
General
unrestricted		 Restricted
£
-
221,798
 Total funds
£
13,647
968,825
760,674 221,798 982,472

14 Analysis of net assets between funds

30

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Notes to the financial statements

For the year ended 31 March 2023 15 Movements in funds

Current year
Restricted funds:
AIM HWHN Apr 20 to Apr 23
Total restricted funds
Designated funds
General funds
Public Health England Sexual
Demontfort University
Sylvia Adams Trust
Burdett CVD Project
Strep A
Royal Foundation ADBB
Pan London
Total funds
Anonymous Family Foundation
PATH
Unrestricted funds:
Baby Breathe
Domestic Abuse
NSPCC LSSP
CHSA
NHS VCSE		 At the start
of the year
£
34,927
40,000
-
14,685
31,056
-
3,022
2,000
2,000
-
-
-
-
-
94,108		 Income
£
34,660
45,000
61,130
40,128
-
22,378
-
-
-
8,500
68,146
46,025
-
-
-		 Expenditure
£
(34,927)
(40,000)
(61,130)
(23,617)
(8,405)
(22,378)
(3,022)
(2,000)
(2,000)
(8,500)
(64,498)
(27,989)
(1,701)
(650)
(74,108)		 Transfers
£
1,701
650		 At the end of
the year
£
34,660
45,000
-
31,196
22,651
-
-
-
-
-
3,648
18,036
-
-
20,000
221,798 325,967 (374,925) 2,351 175,191
-
760,674		 -
1,237,972		 -
(1,024,819)		 150,000
(152,351)		 150,000
821,476
982,472 1,563,939 (1,399,744) - 1,146,667

31

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Notes to the financial statements

For the year ended 31 March 2023

15 Movements in funds (continued)

Purposes of funds

iHV Research Fund

This consists of income raised through fundraising activities and is available to support research purposes including doctoral studies in the form of bursaries.

Burdett Trust (Healthy Weight Healthy Nutrition)

This two year project seeks to up skill all health visitors in nutrition information and best practice in encouraging healthy diets. The training is in the form of a cascade with the trained champions cascading the training to their workplace colleagues.

Anonymous Family Foundation

This funding will support the sustainability of the iHV perinatal mental health champions project. It provides regional and a national forum for the champions to stay connected with the iHV and their colleagues.

Anonymous Family Foundation Nutrition

This funding will support the updating of Healthy Weight Healthy Nutrition training and the provision of four regional training events for Health Visitors.

Burdett Autism

This important one year project will create a toolkit and training for health visitors to support their knowledge and confidence to have meaningful conversations with families of children with autism.

PATH

This European partner project involves 13 partners from the UK, France, the Netherlands and Belgium. It is focused on raising the profile of perinatal mental health in mothers and fathers and will produce a host of new resources for partner countries to use over its 3.5 year life span.

Tiny Lives

The IHV are leading the development of an e-learning module and training event to support health visitors work with parents/ carers of premature babies who have been through NICU in the North East of England. This is a one year project.

PHE Sexual Reproductive Health

Project funder to design and develop resources aimed at advice to expectant and new parents on sexual and reproductive health. All resources now complete e- learning and parent leaflet due for launch. The final report has been submitted for this project.

32

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Notes to the financial statements

For the year ended 31 March 2023

Baby Breathe

Funding successful for this RCT of a postpartum smoking intervention to support new mums stay smoke free. Ethics agreed and recruitment due to commence July 2021

Domestic Abuse

The For Baby’s Sake Trust funded the iHV to develop an online Domestic Abuse digital training toolkit for health visitors.

NSPCC LSSP

Look, Say, Sing, Play is an NSPCC national and local campaign which aims to educate parents about the importance of interacting with and understanding their babies, and provides them with gives them tips and resources to demonstrate show them how to do this, and. The NSPCC developed Look, Say, Sing, Play based on a campaign in the USA, which encouraged parents to be more sensitive and responsive to their child’s thinking, feeling and behaviour. aims to The NSPCC developed a similar campaign for the UK to encourages responsive parenting with the aim of and reducing the risk of abuse and neglect. The NSPPC carried out an evaluation of Look, Say, Sing, Play research to inform future implementation and delivery how the campaign should be delivered.

Genomics

Design, develop and evaluate a series of webinars to raise awareness of genomics, to promote and embed the newly developed Good Practice Points, and to support health visitors’ learning about genomics.

CHSA

This is a time-limited grant funded programme to support the development of Emotional Wellbeing at Work Champions across the UK.

VCSE

Providing support to respond to a potential surge in respiratory infections in children

Stockton/Family Action

The Perinatal Support Services was Established in April 2021 to deliver the a Perinatal Support Service offering early intervention, and support to mothers with diagnosed mental health issues or at risk of developing perinatal mental illness from 16 weeks pregnancy to the child’s second birthday.

HIV SRH

This project will explore HVs current practice, alongside the barriers and enablers to extending the HVs universal role in PC to include advice on contraceptive options and potential for prescribing. These insights will inform the co-production of a bespoke PC training programme for HVs, in partnership with Teesside University

De Montfort

4 year funded project from Sept 2021 – Sept 2025: Cluster Randomised Controlled Trial of a Service to Support the Mental Health & Coping of Parents with Excessively Crying Infants.

Designated Funds

Following two years of surpluses, the Trustees have decide to invest the funds into a new website and membership platform for the benefit of members.

Transfers

Transfers were made in the year against funds which had an allocation against overheads spend and against a few funds which were fully spent at the prior year end and costs weren't fully allocated in the prior year so had shown in unrestricted costs instead.

33

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting

Notes to the financial statements

For the year ended 31 March 2023

15 Movements in funds (continued)

Prior year
Restricted funds:
iHV
Total restricted funds
General funds
Burdett Autism
Burdett restraint
PATH
AIM HWHN Apr 20 to Apr 23
Anonymous Family Foundation Nutrition
PHE Sexual Reproductive Health
Baby Breathe
Domestic Abuse
Anonymous Family Foundation
Tiny Lives
NSPCC LSSP
CHSA
NHS VCSE
Public Health England Sexual
Demontfort University
Sylvia Adams Trust
Total funds
Unrestricted funds:		 At the start
of the year
£
10,019
29,250
40,000
3,404
14,455
11,537
77,308
7,758
17,644
14,686
41,099
-
-
-
-
-
-		 Income
£
-
34,917
40,000
-
-
-
95,596
-
-
39,232
-
60,963
50,000
77,066
45,250
3,400
94,108		 Expenditure
£
(10,019)
(29,240)
(40,000)
-
(389)
(5,725)
(172,904)
750
2,360
(31,387)
(10,043)
(60,963)
(46,978)
(75,066)
(43,250)
(3,400)
-		 Transfers
£
-
-
-
(3,404)
(14,066)
(5,812)
-
(8,508)
(20,004)
(7,846)
-
-
-
-
-
-
-		 At the end of
the year
£
-
34,927
40,000
-
-
-
-
-
-
14,685
31,056
-
3,022
2,000
2,000
-
94,108
267,160 540,532 (526,253) (59,640) 221,798
529,303 1,035,224 (863,494) 59,640 760,674
796,463 1,575,756 (1,389,747) - 982,472

16 Legal status of the charity

The charity is a company limited by guarantee and has no share capital. The liability of each member in the event of winding up is limited to £1.

34

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

Institute of Health Visiting Royal Society for Public Health John Snow House 59 Mansell St London E1 8AN

Email: info@ihv.org.uk Telephone: 44(0)2072 657352

DocuSign Envelope ID: 85F24415-8C52-4B69-8569-911E4D399995

02 August 2023

Email: info@ihv.org.uk Telephone: 44(0)2072 657352

Certificate Of Completion

Envelope Id: 85F244158C524B698569911E4D399995 Status: Completed Subject: Complete with DocuSign: iHV Annual Accounts March 2023 V3.pdf, iHV - Letter of Representation.pdf Source Envelope: Document Pages: 36 Signatures: 5 Envelope Originator: Certificate Pages: 5 Initials: 0 Russelle Lothian AutoNav: Enabled 61 Dublin Street EnvelopeId Stamping: Enabled Edinburgh, Midlothian EH3 6NL Time Zone: (UTC) Dublin, Edinburgh, Lisbon, London russelle.lothian@ct.me IP Address: 90.211.162.138

Record Tracking

Status: Original Holder: Russelle Lothian Location: DocuSign
01 August 2023 16:47 russelle.lothian@ct.me
Signer Events Signature Timestamp
Pamela Goldberg Sent: 01 August 2023
pamelajgoldberg@gmail.com Viewed: 01 August 2023
Security Level: Email, Account Authentication Signed: 02 August 2023
(None)
Signature Adoption: Pre-selected Style
Using IP Address: 31.52.22.2
Electronic Record and Signature Disclosure:
Accepted: 01 August 2023 18:48
ID: 9001ad4c-cf1c-486a-8bd8-8b9e4693220b
Christina Liu Sent: 02 August 2023
christina.xql@gmail.com Viewed: 09 August 2023
Security Level: Email, Account Authentication Signed: 09 August 2023
(None)
Signature Adoption: Drawn on Device
Using IP Address: 165.154.72.202
Signed using mobile
Electronic Record and Signature Disclosure:
Accepted: 09 August 2023 15:13
ID: 1a4b062e-65a4-4823-a927-e5a788834a04
Jeremy Chittleburgh Sent: 09 August 2023
jeremy.chittleburgh@ct.me Viewed: 09 August 2023
Security Level: Email, Account Authentication Signed: 09 August 2023
(None)
Signature Adoption: Drawn on Device
Using IP Address: 194.140.216.2
Electronic Record and Signature Disclosure:
Accepted: 09 August 2023 15:31
ID: e7c5cd26-2e5b-4d55-91cc-5cb95ae1a99d
In Person Signer Events Signature Timestamp
Editor Delivery Events Status Timestamp
Agent Delivery Events Status Timestamp
Intermediary Delivery Events Status Timestamp
Certified Delivery Events Status Timestamp
Carbon Copy Events Status Timestamp
Tim Fleming Sent: 09 August 2023
tim.fleming@ihv.org.uk Viewed: 09 August 2023
Security Level: Email, Account Authentication
(None)
Electronic Record and Signature Disclosure:
Not Offered via DocuSign
Bethany Ferguson Sent: 09 August 2023
bethany.ferguson@ct.me
Security Level: Email, Account Authentication
(None)
Electronic Record and Signature Disclosure:
Not Offered via DocuSign
Caroline Sent: 09 August 2023
Caroline@js2.net
Security Level: Email, Account Authentication
(None)
Electronic Record and Signature Disclosure:
Not Offered via DocuSign
Witness Events Signature Timestamp
Notary Events Signature Timestamp
Envelope Summary Events Status Timestamps
Envelope Sent Hashed/Encrypted 01 August 2023
Certified Delivered Security Checked 09 August 2023
Signing Complete Security Checked 09 August 2023
Completed Security Checked 09 August 2023
Payment Events Status Timestamps
Electronic Record and Signature Disclosure

Electronic Record and Signature Disclosure created on: 14 May 2021 | 11:21 Parties agreed to: Pamela Goldberg, Christina Liu, Jeremy Chittleburgh

ELECTRONIC RECORD AND SIGNATURE DISCLOSURE

From time to time, Chiene + Tait LLP (we, us or Company) may be required by law to provide to you certain written notices or disclosures. Described below are the terms and conditions for providing to you such notices and disclosures electronically through the DocuSign system. Please read the information below carefully and thoroughly, and if you can access this information electronically to your satisfaction and agree to this Electronic Record and Signature Disclosure (ERSD), please confirm your agreement by selecting the check-box next to ‘I agree to use electronic records and signatures’ before clicking ‘CONTINUE’ within the DocuSign system.

Getting paper copies

At any time, you may request from us a paper copy of any record provided or made available electronically to you by us. You will have the ability to download and print documents we send to you through the DocuSign system during and immediately after the signing session and, if you elect to create a DocuSign account, you may access the documents for a limited period of time (usually 30 days) after such documents are first sent to you. After such time, if you wish for us to send you paper copies of any such documents from our office to you, you will be charged a $0.00 per-page fee. You may request delivery of such paper copies from us by following the procedure described below.

Withdrawing your consent

If you decide to receive notices and disclosures from us electronically, you may at any time change your mind and tell us that thereafter you want to receive required notices and disclosures only in paper format. How you must inform us of your decision to receive future notices and disclosure in paper format and withdraw your consent to receive notices and disclosures electronically is described below.

Consequences of changing your mind

If you elect to receive required notices and disclosures only in paper format, it will slow the speed at which we can complete certain steps in transactions with you and delivering services to you because we will need first to send the required notices or disclosures to you in paper format, and then wait until we receive back from you your acknowledgment of your receipt of such paper notices or disclosures. Further, you will no longer be able to use the DocuSign system to receive required notices and consents electronically from us or to sign electronically documents from us.

All notices and disclosures will be sent to you electronically

Unless you tell us otherwise in accordance with the procedures described herein, we will provide electronically to you through the DocuSign system all required notices, disclosures, authorizations, acknowledgements, and other documents that are required to be provided or made available to you during the course of our relationship with you. To reduce the chance of you inadvertently not receiving any notice or disclosure, we prefer to provide all of the required notices and disclosures to you by the same method and to the same address that you have given us. Thus, you can receive all the disclosures and notices electronically or in paper format through the paper mail delivery system. If you do not agree with this process, please let us know as described below. Please also see the paragraph immediately above that describes the consequences of your electing not to receive delivery of the notices and disclosures electronically from us.

How to contact Chiene + Tait LLP:

You may contact us to let us know of your changes as to how we may contact you electronically, to request paper copies of certain information from us, and to withdraw your prior consent to receive notices and disclosures electronically as follows: To contact us by email send messages to: mail@chiene.co.uk

To advise Chiene + Tait LLP of your new email address

To let us know of a change in your email address where we should send notices and disclosures electronically to you, you must send an email message to us at mail@chiene.co.uk and in the body of such request you must state: your previous email address, your new email address. We do not require any other information from you to change your email address.

If you created a DocuSign account, you may update it with your new email address through your account preferences.

To request paper copies from Chiene + Tait LLP

To request delivery from us of paper copies of the notices and disclosures previously provided by us to you electronically, you must send us an email to mail@chiene.co.uk and in the body of such request you must state your email address, full name, mailing address, and telephone number. We will bill you for any fees at that time, if any.

To withdraw your consent with Chiene + Tait LLP

To inform us that you no longer wish to receive future notices and disclosures in electronic format you may:

i. decline to sign a document from within your signing session, and on the subsequent page, select the check-box indicating you wish to withdraw your consent, or you may;

ii. send us an email to mail@chiene.co.uk and in the body of such request you must state your email, full name, mailing address, and telephone number. We do not need any other information from you to withdraw consent.. The consequences of your withdrawing consent for online documents will be that transactions may take a longer time to process..

Required hardware and software

The minimum system requirements for using the DocuSign system may change over time. The - - current system requirements are found here: https://support.docusign.com/guides/signer guide signing-system-requirements.

Acknowledging your access and consent to receive and sign documents electronically

To confirm to us that you can access this information electronically, which will be similar to other electronic notices and disclosures that we will provide to you, please confirm that you have read this ERSD, and (i) that you are able to print on paper or electronically save this ERSD for your future reference and access; or (ii) that you are able to email this ERSD to an email address where you will be able to print on paper or save it for your future reference and access. Further, if you consent to receiving notices and disclosures exclusively in electronic format as described herein, then select the check-box next to ‘I agree to use electronic records and signatures’ before clicking ‘CONTINUE’ within the DocuSign system.

By selecting the check-box next to ‘I agree to use electronic records and signatures’, you confirm that: